Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 3
2006 4
2007 4
2008 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
A Phase 2 study of perifosine in advanced or metastatic breast cancer.
Leighl NB, Dent S, Clemons M, Vandenberg TA, Tozer R, Warr DG, Crump RM, Hedley D, Pond GR, Dancey JE, Moore MJ. Leighl NB, et al. Breast Cancer Res Treat. 2008 Mar;108(1):87-92. doi: 10.1007/s10549-007-9584-x. Epub 2007 Apr 26. Breast Cancer Res Treat. 2008. PMID: 17458693 Clinical Trial.
A Phase II study of oxaliplatin in urothelial cancer.
Winquist E, Vokes E, Moore MJ, Schumm LP, Hoving K, Stadler WM. Winquist E, et al. Urol Oncol. 2005 May-Jun;23(3):150-4. doi: 10.1016/j.urolonc.2004.11.008. Urol Oncol. 2005. PMID: 15907713 Clinical Trial.
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Nimeiri HS, Oza AM, Morgan RJ, Friberg G, Kasza K, Faoro L, Salgia R, Stadler WM, Vokes EE, Fleming GF; Chicago Phase II Consortium; PMH Phase II Consortium; California Phase II Consortium. Nimeiri HS, et al. Gynecol Oncol. 2008 Jul;110(1):49-55. doi: 10.1016/j.ygyno.2008.02.009. Epub 2008 Apr 18. Gynecol Oncol. 2008. PMID: 18423560 Free PMC article. Clinical Trial.
Acute bilateral abducens paralysis due to oxaliplatin.
Winquist E, Vincent M, Stadler W. Winquist E, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):488-9. doi: 10.1093/jnci/95.6.488. J Natl Cancer Inst. 2003. PMID: 12644545 No abstract available.
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study.
Siu LL, Soulieres D, Chen EX, Pond GR, Chin SF, Francis P, Harvey L, Klein M, Zhang W, Dancey J, Eisenhauer EA, Winquist E; Princess Margaret Hospital Phase II Consortium; National Cancer Institute of Canada Clinical Trials Group Study. Siu LL, et al. J Clin Oncol. 2007 Jun 1;25(16):2178-83. doi: 10.1200/JCO.2006.07.6547. J Clin Oncol. 2007. PMID: 17538162 Clinical Trial.
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
Duran I, Kortmansky J, Singh D, Hirte H, Kocha W, Goss G, Le L, Oza A, Nicklee T, Ho J, Birle D, Pond GR, Arboine D, Dancey J, Aviel-Ronen S, Tsao MS, Hedley D, Siu LL. Duran I, et al. Br J Cancer. 2006 Nov 6;95(9):1148-54. doi: 10.1038/sj.bjc.6603419. Epub 2006 Oct 10. Br J Cancer. 2006. PMID: 17031397 Free PMC article. Clinical Trial.
A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia.
Gomez-Abuin G, Winquist E, Stadler WM, Pond G, Degendorfer P, Wright J, Moore MJ. Gomez-Abuin G, et al. Invest New Drugs. 2007 Apr;25(2):181-5. doi: 10.1007/s10637-006-9009-4. Epub 2006 Sep 16. Invest New Drugs. 2007. PMID: 16983508 Clinical Trial.
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.
Townsley CA, Major P, Siu LL, Dancey J, Chen E, Pond GR, Nicklee T, Ho J, Hedley D, Tsao M, Moore MJ, Oza AM. Townsley CA, et al. Br J Cancer. 2006 Apr 24;94(8):1136-43. doi: 10.1038/sj.bjc.6603055. Br J Cancer. 2006. PMID: 16570047 Free PMC article. Clinical Trial.
12 results
Jump to page